GGrantIndex
Sort

15,842 grants matching pancreatic cancer

Optimized targeted radiotherapy of pancreatic cancer

$400,000
Pinku Mukherjee · Oncotab, Inc · R41 · FY2025 · CA

Phase 2 Study of Folfirinox Followed by Ipilimumab/GVAX in Pancreatic Cancer

$400,000
Dung T Le · Johns Hopkins University · R01 · FY2016 · FD

Phase 2 Study of Folfirinox Followed by Ipilimumab/GVAX in Pancreatic Cancer

$400,000
Dung T Le · Johns Hopkins University · R01 · FY2017 · FD

Extending the in vivo half-life of a novel engineered mammalian asparaginase via its binding to human serum albumin

$399,999
Amanda M Schalk · Enzyme By Design, Inc. · R43 · FY2020 · CA

Integration of non-invasive deep tissue microwave thermometry in the VectRx hyperthermia device in a transgenic liver tumor pig model

$399,999
Pierre N Floriano · Neotherma Oncology, Inc. · R43 · FY2023 · CA

Sub-100 nm and scalable self-therapeutic nanoparticles to target autophagy in pancreatic cancer

$399,999
Tzu-Yin Lin · Theranostec, Inc. · R43 · FY2022 · CA

Novel multispectral optoacoustic tomography contrast agents for evaluation of early response to radiation therapy

$399,997
Joshua Akhigbe · Nirvana Sciences, Inc. · R43 · FY2021 · CA

Stroma-penetrating nanomedicine to improve treatment for pancreatic cancer

$399,970
Katherine Marie Eichinger · Duo Oncology Inc · R41 · FY2024 · CA

Regulation of KRAS plasma membrane targeting by defined glycosphingolipids.

$399,968
John F Hancock · University Of Texas Hlth Sci Ctr Houston · R01 · FY2023 · GM

Translational Assays for Inflammatory Biomarkers for the Risk Stratification of Pancreatic Cystic Lesions

$399,885
Daniel Sheik · Amplified Sciences Inc · R43 · FY2023 · CA

Endoscopic Ultrasound-guided In Vivo Confocal Laser Endomicroscopy as an Imaging Biomarker for the Accurate Risk Stratification of Intraductal Papillary Mucinous Neoplasms

$399,838
Somashekar G. Krishna · Ohio State University · R01 · FY2023 · CA

ALLOGENIC PANCREATIC TUMOR VACCINE CELL LINE

$399,791
Johns Hopkins University · R01 · FY2000 · CA

Modulation of the gut microbiome to enhance efficacy of immunotherapy in pancreatic adenocarcinoma

$399,752
Deepak Saxena · Periomics Care, Llc · R41 · FY2020 · CA

Simultaneous Targeting of Tumor and Stroma Cells to Enhance Solid Tumor CAR-T Cell Therapy

$399,658
Nicole J. Shirkey-Son · Luminary Therapeutics, Inc. · R43 · FY2021 · CA

Chronic Pancreatitis, Diabetes and Pancreatic Cancer: A Prospective Approach

$399,658
Stephen K. Van Den Eeden · Kaiser Foundation Research Institute · U01 · FY2017 · DK

EXPLOITING PATTERNS OF GENE ESSENTIALITY IN HUMAN CELLS TO PREDICT GENE FUNCTION, SYNTHETIC LETHALITY, AND CANCER TARGETS

$399,258
Glen Traver Hart · University Of Tx Md Anderson Can Ctr · R35 · FY2022 · GM

EXPLOITING PATTERNS OF GENE ESSENTIALITY IN HUMAN CELLS TO PREDICT GENE FUNCTION, SYNTHETIC LETHALITY, AND CANCER TARGETS

$399,258
Glen Traver Hart · University Of Tx Md Anderson Can Ctr · R35 · FY2019 · GM

EXPLOITING PATTERNS OF GENE ESSENTIALITY IN HUMAN CELLS TO PREDICT GENE FUNCTION, SYNTHETIC LETHALITY, AND CANCER TARGETS

$399,258
Glen Traver Hart · University Of Tx Md Anderson Can Ctr · R35 · FY2018 · GM

EXPLOITING PATTERNS OF GENE ESSENTIALITY IN HUMAN CELLS TO PREDICT GENE FUNCTION, SYNTHETIC LETHALITY, AND CANCER TARGETS

$399,258
Glen Traver Hart · University Of Tx Md Anderson Can Ctr · R35 · FY2021 · GM

EXPLOITING PATTERNS OF GENE ESSENTIALITY IN HUMAN CELLS TO PREDICT GENE FUNCTION, SYNTHETIC LETHALITY, AND CANCER TARGETS

$399,258
Glen Traver Hart · University Of Tx Md Anderson Can Ctr · R35 · FY2020 · GM

Engineering therapeutic and diagnostic proteins for tumor biomarker mesothelin

$399,232
Sarah J. Moore · Smith College · R15 · FY2015 · CA

Modeling Marginal Zone Lymphomagenesis

$399,187
Victor Yazbeck · Virginia Commonwealth University · R21 · FY2024 · CA

Core 1: Tumor and Microenvironment Heterogeneity Core (TMH Core)

$399,061
Susan M Kaech · Salk Institute For Biological Studies · P01 · FY2024 · CA

Role of type 2 immune response in pancreatic cancer tumorigenesis

$399,058
Prasenjit Dey · Roswell Park Cancer Institute Corp · R01 · FY2023 · CA

Caliper Life Sciences Xenogen IVIS Imager

$399,053
Zena Werb · University Of California, San Francisco · S10 · FY2010 · RR